Immunomedics Company Profile (NASDAQ:IMMU)

About Immunomedics

Immunomedics logoImmunomedics, Inc. is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders and other serious diseases. The Company's technologies allow it to create humanized antibodies in unlabeled or naked form, or conjugated with radioactive isotopes, chemotherapeutics, cytokines or toxins. Its product candidates include 90Y-clivatuzumab tetraxetan. Its radiolabeled antibody is in a Phase III registration trial in patients with advanced pancreatic cancer. Its portfolio of investigational products also includes antibody-drug conjugates (ADCs). Its ADCs consist of sacituzumab govitecan (IMMU-132) and labetuzumab govitecan (IMMU-130), which are in Phase II trials for a number of solid tumors and metastatic colorectal cancer (mCRC), respectively. It has other product candidates that target solid tumors and hematologic malignancies, as well as other diseases, in clinical and pre-clinical development-stages.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: IMMU
  • CUSIP: 45290710
Key Metrics:
  • Previous Close: $2.97
  • 50 Day Moving Average: $2.64
  • 200 Day Moving Average: $2.89
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -7.82
  • P/E Growth: 0.00
  • Market Cap: $284.72M
  • Outstanding Shares: 95,866,000
  • Beta: 1.42
Additional Links:
Companies Related to Immunomedics:

Analyst Ratings

Consensus Ratings for Immunomedics (NASDAQ:IMMU) (?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $5.00 (68.35% upside)

Analysts' Ratings History for Immunomedics (NASDAQ:IMMU)
Show:
DateFirmActionRatingPrice TargetDetails
6/21/2016Wells Fargo & Co.DowngradeOutperform -> Market PerformView Rating Details
6/6/2016Jefferies GroupReiterated RatingBuy$5.00View Rating Details
7/29/2015Oppenheimer Holdings Inc.Reiterated RatingOutperformView Rating Details
9/30/2014Panmure GordonReiterated RatingBuyView Rating Details
8/27/2014R. F. LaffertyDowngradeBuy -> Neutral$4.00View Rating Details
(Data available from 8/23/2014 forward)

Earnings

Earnings History for Immunomedics (NASDAQ:IMMU)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/17/2016        
8/17/2016Q416($0.11)($0.17)$1.20 millionViewListenView Earnings Details
5/4/2016Q3($0.13)($0.15)$2.13 millionViewN/AView Earnings Details
2/3/2016Q216($0.14)($0.15)$1.23 millionViewN/AView Earnings Details
11/5/2015Q116($0.14)($0.16)$1.23 millionViewN/AView Earnings Details
8/19/2015Q415($0.13)($0.13)$1.13 million$2.40 millionViewListenView Earnings Details
5/6/2015($0.13)($0.13)ViewN/AView Earnings Details
2/5/2015Q215($0.13)($0.12)$1.38 millionViewN/AView Earnings Details
11/5/2014($0.12)($0.13)ViewN/AView Earnings Details
8/25/2014Q414($0.12)($0.13)$1.20 million$1.20 millionViewN/AView Earnings Details
5/7/2014($0.11)($0.11)ViewN/AView Earnings Details
2/10/2014Q214($0.10)($0.10)$1.20 million$1.20 millionViewN/AView Earnings Details
8/22/2013Q4 2013($0.12)($0.09)$0.81 million$1.40 millionViewN/AView Earnings Details
5/8/2013Q3 2013($0.10)$0.11$0.97 million$1.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Immunomedics (NASDAQ:IMMU)
Current Year EPS Consensus Estimate: $-0.47 EPS
Next Year EPS Consensus Estimate: $-0.38 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.13)($0.13)($0.13)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Immunomedics (NASDAQ:IMMU)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Immunomedics (NASDAQ:IMMU)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/13/2016Cynthia L GoldenbergCEOSell371,990$3.03$1,127,129.70View SEC Filing  
6/8/2016Cynthia L GoldenbergCEOSell41,441$3.62$150,016.42View SEC Filing  
6/8/2016David M GoldenbergChairmanSell353,010$3.88$1,369,678.80View SEC Filing  
6/7/2016Cynthia L GoldenbergCEOSell4,600$4.01$18,446.00View SEC Filing  
6/7/2016David M GoldenbergChairmanSell12,300$3.98$48,954.00View SEC Filing  
6/6/2016Cynthia L GoldenbergCEOSell63,959$4.09$261,592.31View SEC Filing  
6/6/2016David M GoldenbergChairmanSell110,322$4.09$451,216.98View SEC Filing  
6/15/2015David M GoldenbergChairmanSell210,991$4.08$860,843.28View SEC Filing  
6/12/2015Brian A MarkisonDirectorSell5,564$4.22$23,480.08View SEC Filing  
6/12/2015David M GoldenbergChairmanSell359,653$4.32$1,553,700.96View SEC Filing  
6/9/2015Mary E PaetzoldDirectorSell4,677$4.60$21,514.20View SEC Filing  
6/5/2015Don C StarkDirectorSell5,732$4.14$23,730.48View SEC Filing  
12/11/2014Mary E PaetzoldDirectorSell10,000$4.71$47,100.00View SEC Filing  
12/9/2014Don C StarkDirectorSell5,500$4.51$24,805.00View SEC Filing  
9/13/2013Don StarkDirectorSell10,000$6.08$60,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Immunomedics (NASDAQ:IMMU)
DateHeadline
kcregister.com logoTraders Are Watching: Immunomedics Inc. (NASDAQ:IMMU), Alibaba Group Holding Ltd (NYSE:BABA), Marchex, Inc ... - KC Register (NASDAQ:IMMU)
www.kcregister.com - August 22 at 10:13 AM
4-traders.com logoIMMUNOMEDICS : ANNOUNCES CONFERENCE CALL AND WEBCAST FOR FOURTH QUARTER AND FISCAL YEAR 2016 FINANCIAL RESULTS (NASDAQ:IMMU)
www.4-traders.com - August 19 at 5:36 PM
investors.com logoImmunomedics hails latest pre-clinical results in cancer study - Proactive Investors USA & Canada (NASDAQ:IMMU)
www.proactiveinvestors.com - August 19 at 8:34 AM
4-traders.com logoIMMUNOMEDICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) (NASDAQ:IMMU)
www.4-traders.com - August 18 at 5:38 PM
investors.com logoImmunomedics hails latest pre-clinical results in cancer study (NASDAQ:IMMU)
www.proactiveinvestors.com - August 18 at 5:38 PM
marketwatch.com logo10-K: IMMUNOMEDICS INC (NASDAQ:IMMU)
www.marketwatch.com - August 18 at 5:38 PM
finance.yahoo.com logoEdited Transcript of IMMU earnings conference call or presentation 17-Aug-16 9:00pm GMT (NASDAQ:IMMU)
finance.yahoo.com - August 18 at 5:38 PM
biz.yahoo.com logoIMMUNOMEDICS INC Files SEC form 10-K, Annual Report (NASDAQ:IMMU)
biz.yahoo.com - August 18 at 5:38 PM
News IconEarnings Watch: Immunomedics, Inc. (NASDAQ:IMMU) - Post Registrar (NASDAQ:IMMU)
postregistrar.com - August 18 at 8:38 AM
nasdaq.com logoEarnings Reaction History: Immunomedics Inc., 100.0% Follow ... - Nasdaq (NASDAQ:IMMU)
www.nasdaq.com - August 18 at 8:38 AM
finance.yahoo.com logoPreclinical Study on Enhancing Sacituzumab Govitecan (IMMU-132) Activity in SN-38-Resistant Cancer Cells Published (NASDAQ:IMMU)
finance.yahoo.com - August 18 at 8:38 AM
finance.yahoo.com logo7:01 am Immunomedics announces that adding an inhibitor of ATP-binding cassette transporters to sacituzumab govitecan increased the median survival of mice bearing an SN-38-resistant human gastric cancer cell line, results published in Mole (NASDAQ:IMMU)
finance.yahoo.com - August 18 at 8:38 AM
reuters.com logoBRIEF-Immunomedics reports Q4 loss per share $0.17 (NASDAQ:IMMU)
www.reuters.com - August 17 at 5:50 PM
4-traders.com logoImmunomedics : reports 4Q loss (NASDAQ:IMMU)
www.4-traders.com - August 17 at 5:50 PM
sg.finance.yahoo.com logoImmunomedics reports 4Q loss (NASDAQ:IMMU)
sg.finance.yahoo.com - August 17 at 5:50 PM
biz.yahoo.com logoQ4 2016 Immunomedics Inc Earnings Release - After Market Close (NASDAQ:IMMU)
biz.yahoo.com - August 17 at 8:43 AM
News IconTrading the Biotech News: Illumina Inc. (ILMN), Immunomedics Inc. (IMMU) - The Voice Registrar (NASDAQ:IMMU)
voiceregistrar.com - August 16 at 5:48 PM
News IconImmunomedics, Inc. Shares Rallied 14% in July as Shareholders Picked Up the Pieces - Madison.com (NASDAQ:IMMU)
host.madison.com - August 11 at 5:53 PM
finance.yahoo.com logoImmunomedics Announces Conference Call And Webcast For Fourth Quarter And Fiscal Year 2016 Financial Results (NASDAQ:IMMU)
finance.yahoo.com - August 11 at 8:38 AM
fool.com logoImmunomedics, Inc. Shares Rallied 14% in July as Shareholders Picked Up the Pieces - Motley Fool (NASDAQ:IMMU)
www.fool.com - August 10 at 8:28 AM
News IconBiotech Stocks Worth a Closer Look: Immunomedics Inc. (NASDAQ:IMMU), Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - The Voice Registrar (NASDAQ:IMMU)
voiceregistrar.com - August 9 at 8:39 AM
ftsenews.co.uk logoNew Broker Ratings For Immunomedics, Inc. (IMMU) - FTSE News (NASDAQ:IMMU)
www.ftsenews.co.uk - August 9 at 8:39 AM
finance.yahoo.com logoDEADLINE TODAY: Khang & Khang LLP Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm (NASDAQ:IMMU)
finance.yahoo.com - August 8 at 5:50 PM
finance.yahoo.com logoFINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics Inc. (IMMU) and Lead Plaintiff Deadline - August 8, 2016 (NASDAQ:IMMU)
finance.yahoo.com - August 8 at 10:20 AM
News IconIMMUNOMEDICS 72 HOUR DEADLINE ALERT: APPROXIMATELY 72 HOURS REMAIN; FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS… (NASDAQ:IMMU)
forextv.com - August 7 at 9:55 AM
finance.yahoo.com logoIMMUNOMEDICS 72 HOUR DEADLINE ALERT: APPROXIMATELY 72 HOURS REMAIN; FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS of Deadline in Class Action Lawsuit Against Immunomedics Inc. - IMMU (NASDAQ:IMMU)
finance.yahoo.com - August 6 at 8:29 AM
equities.com logoImmunomedics Inc. (IMMU) Jumps 5.47% on August 05 - Equities.com (NASDAQ:IMMU)
www.equities.com - August 5 at 5:45 PM
finance.yahoo.com logoFINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics Inc. (IMMU) and Lead Plaintiff Deadline: August 8, 2016 (NASDAQ:IMMU)
finance.yahoo.com - August 5 at 5:45 PM
News IconStock in the Spotlight: Immunomedics Inc. (NASDAQ:IMMU) | News ... - News Oracle (NASDAQ:IMMU)
www.newsoracle.com - August 4 at 8:38 AM
globenewswire.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds ... - GlobeNewswire (press release) (NASDAQ:IMMU)
globenewswire.com - August 4 at 8:38 AM
benzinga.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP... (NASDAQ:IMMU)
www.benzinga.com - August 3 at 5:56 PM
finance.yahoo.com logoDEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of a Class Action against Immunomedics Inc. (IMMU) and Lead Platintiff Deadline: August 8, 2016 (NASDAQ:IMMU)
finance.yahoo.com - August 3 at 5:56 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Immunomedics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016 – IMMU (NASDAQ:IMMU)
finance.yahoo.com - August 3 at 5:56 PM
globenewswire.com logoRosen Law Firm Reminds Immunomedics, Inc. Investors of Important August 8 Deadline in Class Action - IMMU - GlobeNewswire (press release) (NASDAQ:IMMU)
globenewswire.com - August 3 at 8:50 AM
finance.yahoo.com logoAUGUST 8, 2016 DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm (NASDAQ:IMMU)
finance.yahoo.com - August 3 at 8:50 AM
finance.yahoo.com logoRosen Law Firm Reminds Immunomedics, Inc. Investors of Important August 8 Deadline in Class Action - IMMU (NASDAQ:IMMU)
finance.yahoo.com - August 2 at 5:51 PM
finance.yahoo.com logoAPPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm (NASDAQ:IMMU)
finance.yahoo.com - August 2 at 10:26 AM
marketwired.com logoINVESTOR ALERT: Hagens Berman Reminds Immunomedics, Inc. (NASDAQ: IMMU) Investors of August 8, 2016 Lead ... - Marketwired (press release) (NASDAQ:IMMU)
www.marketwired.com - August 1 at 5:30 PM
finance.yahoo.com logoINVESTOR ALERT: Hagens Berman Reminds Immunomedics, Inc. (NASDAQ: IMMU) Investors of August 8, 2016 Lead Plaintiff Deadline (NASDAQ:IMMU)
finance.yahoo.com - August 1 at 9:30 AM
businesswire.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Immunomedics, Inc. of a Class Action Lawsuit and ... - Business Wire (press release) (NASDAQ:IMMU)
www.businesswire.com - July 30 at 8:32 AM
finance.yahoo.com logoIMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm (NASDAQ:IMMU)
finance.yahoo.com - July 29 at 11:11 AM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Immunomedics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016 (NASDAQ:IMMU)
finance.yahoo.com - July 29 at 9:35 AM
finance.yahoo.com logoBrower Piven Alerts Shareholders of Upcoming Deadline in Class Action Lawsuit and Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Immunomedics, Inc. to Contact the Firm - IMMU (NASDAQ:IMMU)
finance.yahoo.com - July 28 at 3:45 PM
News IconIntraday Active Biotech Stocks News: Immunomedics Inc. (NASDAQ:IMMU), Keryx Biopharmaceuticals Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:IMMU)
voiceregistrar.com - July 28 at 8:37 AM
ftsenews.co.uk logoImmunomedics, Inc. (IMMU) Updated Price Targets - FTSE News (NASDAQ:IMMU)
www.ftsenews.co.uk - July 27 at 8:26 AM
streetupdates.com logoRecent Analysts Rating Overview: Abbott Laboratories (NYSE:ABT ... - Street Updates (NASDAQ:IMMU)
www.streetupdates.com - July 27 at 8:26 AM
streetupdates.com logoNoteworthy Buzzers: Endo International plc (NASDAQ:ENDP) , Immunomedics, Inc. (NASDAQ:IMMU) - Street Updates (NASDAQ:IMMU)
www.streetupdates.com - July 27 at 8:26 AM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm (NASDAQ:IMMU)
finance.yahoo.com - July 26 at 11:53 AM
finance.yahoo.com logoDEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of a Class Action against Immunomedics Inc. (IMMU) and Lead Platintiff Deadline: August 8, 2016 (NASDAQ:IMMU)
finance.yahoo.com - July 26 at 10:24 AM
fortune.com logoImmunomedics Inc. (NASDAQ:IMMU) at $2.68: How much higher it can go - Review Fortune (NASDAQ:IMMU)
reviewfortune.com - July 25 at 5:41 PM

Social

Immunomedics (NASDAQ:IMMU) Chart for Tuesday, August, 23, 2016


Last Updated on 8/23/2016 by MarketBeat.com Staff